Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GalenicumSAG is an established GMP-certified pharmaceutical contract manufacturing organization based near Madrid, Spain. The plant has over four decades of history in drug production and was acquired by the Galenicum Group in 2013 from Merck & Co./Schering-Plough. It offers end-to-end development and commercial-scale production services for multiple dosage forms—tablets, capsules, creams, liquids—and supplies both local and international markets. The facility played a critical role during the COVID pandemic as one of Spain’s main manufacturers of paracetamol.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GalenicumSAG.